Pharmacoeconomics and Health Outcomes Research Iberia (Spain)

Recent papers from Pharmacoeconomics and Health Outcomes Research Iberia (Spain)

1. Cost-effectiveness of microaxial flow pump versus standard of Care in the management of Cardiogenic shock in SpainExpert Review of Pharmacoeconomics & Outcomes Research · 2026
2. Effects of specialized pro-resolving mediators and telerehabilitation on fatigue, dyspnea, and quality of life in post‑COVID‑19 condition: the ARACOV-02 randomized controlled trialBMC Complementary Medicine and Therapies · 2026
3. Incidence, prevalence, and ketoacidosis at onset of type 1 diabetes in Spain: a systematic review and critical assessment of the available evidenceBMC Endocrine Disorders · 2026
4. Short-term economic impact of early leaks following metabolic bariatric surgeryBritish journal of surgery · 2026
5. Examining the emotional impact and financial strain on caregivers of those with Duchenne muscular dystrophy in Saudi Arabia: findings from a questionnaire-based cross-sectional studyFrontiers in Psychology · 2026
6. Cost-effectiveness of community interventions to promote awareness, testing and treatment of hepatitis B and C in migrant populations in CataloniaScientific Reports · 2026
7. Interdental brushes for improving oral hygiene in patients with fixed orthodontic appliances: a systematic reviewFrontiers in Oral Health · 2026
8. IFUCISTRATEGY: A Spanish Survey on the Management of Invasive Fungal Infection (IFI) in Critically Ill PatientsJournal of Fungi · 2026
9. Evidence Synthesis via Indirect Treatment Comparisons in the European Framework of Joint Clinical AssessmentEpidemiologia · 2026
10. Budget impact analysis of robot-assisted versus conventional spine surgery in SpainJournal of Robotic Surgery · 2026
11. Recommendations for the diagnosis of patients with hepatitis delta virus (HDV) in Spain.2026
12. Assessing the real-world impact of interstitial lung disease in patients with rheumatoid arthritis on healthcare resources and treatment patterns through natural language processingEULAR Rheumatology Open · 2026
13. A Cost Analysis of Adverse Event Management of Systemic Therapies for Metastatic Colorectal Cancer on Patients with at Least Two Previous Lines of Treatment in SpainClinicoEconomics and Outcomes Research · 2026
14. Chronic Kidney Disease (CKD): Systematic Review of the Cost Effectiveness of SGLT2 Inhibitors and Other Novel Nephroprotective DrugsPharmacoEconomics · 2026
15. Economic burden and cost of non-adherence in type 2 diabetes: a systematic review of middle- and high-income countriesHealth Economics Review · 2026
16. Harmonising Life Cycle Assessment of Biosolids Processing Systems: Reducing Variability and Identifying Key Sources of VariationEnvironmental Science & Technology · 2026
17. Cost minimization and budget impact model for introducing the fully liquid combined acellular hexavalent vaccine into the Dominican Republic’s expanded immunization planExpert Review of Pharmacoeconomics & Outcomes Research · 2026
18. Investigating the therapeutic profile of velaglucerase alfa in paediatric patients with Gaucher disease: a systematic review across all paediatric age groupsOrphanet Journal of Rare Diseases · 2026
19. Cost of managing brain metastases in ALK-positive advanced NSCLC patients receiving first-line ALK TKIs in ChinaLung Cancer Management · 2026
20. Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in SpainPharmacoEconomics - Open · 2026